[Clonality and stem cell defects in the molecular pathology of chronic myeloproliferative disorders].
The chronic myeloproliferative disorders (CMD) are characterized by sustained or progressive proliferations of bone marrow cells, affecting one or more lineages in varying combinations. They are classified in 4 subgroups but transitional forms and transformations among the different entities are common. Analysing RFLPs and methylation patterns of X-chromosomal genes we could show, that in each entity granulocytes as well as bone marrow cells are of monoclonal origin. These findings support the view that all forms of CMD have in common that they arise from a multipotent hematopoietic stem cell. CML can be differentiated from all other forms of CMD by the Philadelphia-chromosome which on the molecular level has been revealed as bcr-abl gene junction. We investigated 258 cases of CMD for rearrangement of the bcr gene and found that it selectively occurred in CML. The methods applied can be of diagnostic value in differentiating reactive from neoplastic proliferations by analysis of clonality, and in differentiation of CML from other types of CMD by detection of the bcr-rearrangement.
Kreipe
H
H
Institut für Pathologie der Universität, Kiel.
Radzun
H J
HJ
Bartels
H
H
von Heyden
H W
HW
Löffler
H
H
Parwaresch
M R
MR
D001853:Bone Marrow / Q000473:pathology*; D003114:Colony-Forming Units Assay; D006412:Hematopoietic Stem Cells / Q000473:pathology*; D006801:Humans; D009196:Myeloproliferative Disorders / Q000235:genetics / Q000473:pathology*; D010677:Philadelphia Chromosome; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length
Klonalität und Stammzelldefekt in der molekularen Pathologie chronischer myeloproliferativer Erkrankungen.